• 297 Citations
  • 8 h-Index
19982018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Larry D Anderson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Immunization Medicine & Life Sciences
Graft vs Host Disease Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
Transplants Medicine & Life Sciences
Cancer Vaccines Medicine & Life Sciences
Bone Marrow Transplantation Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2018

  • 297 Citations
  • 8 h-Index
  • 15 Article
  • 1 Editorial
  • 1 Letter
3 Citations (Scopus)

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results

Richardson, P. G., Bensinger, W. I., Huff, C. A., Costello, C. L., Lendvai, N., Berdeja, J. G., Anderson, L. D., Siegel, D. S., Lebovic, D., Jagannath, S., Laubach, J. P., Stockerl-Goldstein, K. E., Kwei, L., Clow, F., Elias, L., Salman, Z., Graef, T., Bilotti, E. & Vij, R., Mar 1 2018, In : British Journal of Haematology. 180, 6, p. 821-830 10 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Safety
Immunomodulation
Syncope

Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory waldenström macroglobulinemia: Evidence for a graft-versus-lymphoma effect

Maffini, E., Anderson, L. D., Sandmaier, B. M., Green, D. J., Storer, B. E., Niederwieser, D., Maziarz, R. T., Maloney, D. G. & Storb, R., Jun 3 2018, In : Haematologica. 103, 6, p. e252-e255

Research output: Contribution to journalLetter

Waldenstrom Macroglobulinemia
Cell Transplantation
Lymphoma
Transplants
7 Citations (Scopus)

Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma

Chari, A., Larson, S., Holkova, B., Cornell, R. F., Gasparetto, C., Karanes, C., Matous, J. V., Niesvizky, R., Valent, J., Lunning, M., Usmani, S. Z., Anderson, L. D., Chang, L., Lee, Y., Pak, Y., Salman, Z., Graef, T., Bilotti, E. & Chhabra, S., Apr 5 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Cytogenetics
Thrombocytopenia
Dexamethasone
Disease-Free Survival
14 Citations (Scopus)

Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial

Trudel, S., Lendvai, N., Popat, R., Voorhees, P. M., Reeves, B., Libby, E. N., Richardson, P. G., Anderson, L. D., Sutherland, H. J., Yong, K., Hoos, A., Gorczyca, M. M., Lahiri, S., He, Z., Austin, D. J., Opalinska, J. B. & Cohen, A. D., Dec 1 2018, In : The Lancet Oncology. 19, 12, p. 1641-1653 13 p.

Research output: Contribution to journalArticle

B-Cell Maturation Antigen
Multiple Myeloma
Maximum Tolerated Dose
Therapeutics
Safety
1 Citation (Scopus)